Ask AI
ProCE Banner Activity

CCO Independent Conference Coverage of IDWeek and EACS 2025: HIV Update Webinar 1

Video

Stream this webinar to revisit discussions led by global experts, featuring the latest updates on HIV treatment and prevention from the 2025 IDWeek and EACS conferences.

Released: November 05, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners in applying new findings to optimize treatment and prevention strategies for HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Joseph J. Eron Jr., MD: consultant/advisor/speaker: AbbVie, Gilead, Merck, ViiV; researcher: Gilead.

Aadia I. Rana, MD, FIDSA, has no relevant financial relationships to disclose.